Multi tyrosin kinase inihibition by Axitinib in the treatment of human meningiomas

Jan Walter, Diana Freitag, Susanne Grube, Pedro Dünisch, Rolf Kalff & Christian Ewald
Objective: Axitinib is a small-molecule protein-tyrosine kinase receptor inhibitor specifically targeting the family of vascular endothelial growth factor receptors, in addition to platelet-derived growth factor receptors and proto-oncogene c-Kit. It's the aim of this study to investigate the effects[for full text, please go to the a.m. URL]